Gilead Sciences, Inc. (NASDAQ: GILD), one of the world’s leading biopharmaceutical companies, is headquartered in Foster City, California. Today, Gilead CEO Daniel O’Day serves as Chairman and Chief Executive Officer, leading a company with $29.4 billion in annual revenue and a workforce of approximately 18,000 employees. Appointed in March 2019 after a distinguished 30-year career […]

⚠ Leadership Update: John F. Milligan, Ph.D. served as CEO of Gilead Sciences from March 2016 to December 2018. The current Chairman & CEO is Daniel O’Day (since March 2019). Gilead Sciences, Inc. (NASDAQ: GILD), a leading American biopharmaceutical company headquartered in Foster City, California, was led by John F. Milligan, Ph.D. as President and […]